Gilead Sciences' Yeztugo receives nod; the first and only US FDA─approved HIV prevention option offering 6 months of ...
Foster City-headquartered Gilead Sciences Inc, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, announced that the US FDA has approved Yeztugo (lenacapavir) - the company’s injectable HIV-1 …